| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.0093 | 1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.00056 | 1 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.00045 | 1 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.00039 | 1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.00043 | 1 |